Premium
Treatment specific utility‐weightings are needed for cost–utility analysis in metastatic melanoma: reply from the authors
Author(s) -
MatterWalstra K.,
Braun R.,
Kolb C.,
Ademi Z.,
Dummer R.,
Pestalozzi B.C.,
Schwenkglenks M.
Publication year - 2016
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.14279
Subject(s) - metastatic melanoma , medicine , cost–utility analysis , melanoma , intensive care medicine , oncology , risk analysis (engineering) , cancer research , cost effectiveness
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom